Osaka Soda Co (4046) Q4 2026 earnings summary
Event summary combining transcript, slides, and related documents.
Q4 2026 earnings summary
18 May, 2026Executive summary
Net sales rose 3.7% year-over-year to ¥99,961 million, with operating profit up 33.1% to ¥17,634 million and profit attributable to owners of parent up 49.6% to ¥15,460 million, all record highs.
Growth was driven by strong performance in Basic chemicals and Healthcare, while Functional chemicals and Trading/Others saw declines.
The company completed its medium-term plan and launched a new plan targeting ¥30,000 million operating income by FY2030.
Financial highlights
Gross profit increased to ¥33,728 million from ¥28,946 million year-over-year.
Comprehensive income more than doubled to ¥20,453 million from ¥9,904 million.
Cash and cash equivalents at year-end were ¥48,802 million, up ¥5,488 million year-over-year.
Equity-to-asset ratio improved to 75.6% from 75.1%.
Outlook and guidance
FY2027 forecast: net sales ¥106,000 million (+6.0%), operating profit ¥19,000 million (+7.7%), profit attributable to owners of parent ¥13,600 million (-12.0%).
New medium-term plan focuses on healthcare growth, new business creation, and management foundation strengthening.
Latest events from Osaka Soda Co
- Operating profit jumped 41.7% on 7.6% higher sales, led by healthcare and functional chemicals.4046
Q2 202518 May 2026 - Profits and sales rose on strong healthcare and chemicals demand; stock split set for October.4046
Q1 202518 May 2026 - Profits surged on healthcare growth and supply recovery, with record highs forecast for FY2025 and FY2026.4046
Q4 202518 May 2026 - Profits surged on strong healthcare demand and supply recovery; full-year outlook maintained.4046
Q3 202518 May 2026 - Profits rose sharply despite lower sales, with upward guidance and enhanced shareholder returns.4046
Q2 202618 May 2026 - First-quarter profit rose 9.4% year-on-year, driven by healthcare and basic chemicals growth.4046
Q1 202618 May 2026 - Operating profit surged 21.6% and net profit rose 34.0% despite a 1.3% sales decline.4046
Q3 202618 May 2026